Benicar/Olmesartan Alert Revised

The FDA has announced that after review, it has revised its previous warning about possible increased risk of cardiovascular events when diabetic patients use olmesartan to reduce blood pressure.  Olmesartan is sold as Benicar, Benicar HCT, Azor, Tribenzor, and Generics.  While the FDA concludes that benefits outweigh risks, they are asking that information from some of the studies they reviewed be included in the drug label.  For details see http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm402616.htm.

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s